Dave is responsible for managing the finance and administration functions at Enko Chem, Inc., a crop protection start-up company using DNA-Encoded libraries, AI and Machine Learning and Structure-Based Design to find and select the right treatments for the right chemical targets, faster and more effectively. From 2009 to 2022, he helped managed the investment function at CI, which included staffing, portfolio and risk management, outreach, budget planning and performance measurement. He was also responsible for oversight of the Connecticut Bioscience Innovation Fund (CBIF) and the Regenerative Medicine Research Fund (RMRF). When he joined CI in 2009 as senior managing director of investments, Dave had extensive senior-level experience in operations and finance, including more than 10 years as executive vice president, treasurer and CFO of CuraGen Corporation, a former CI portfolio company. Dave began his professional career with Coopers & Lybrand in Hartford, Connecticut (now part of PricewaterhouseCoopers).